Phibro Animal Health | PAHC - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Align Technology USD 303.5M 60.47M 2026-03
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Assertio Holdings USD 8.89M 2.29M 2024-06
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.88M 338K 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Henry Schein USD 2.3B 145M 2026-03
Idexx Laboratories USD 418.08M 14.38M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Merck USD 2.94B 380M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pacira USD 50.74M 3.89M 2026-03
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Zoetis USD 743M 60M 2025-12